+

WO2015058103A1 - Method and device for detecting molecules or particles using fractionalized volumes - Google Patents

Method and device for detecting molecules or particles using fractionalized volumes Download PDF

Info

Publication number
WO2015058103A1
WO2015058103A1 PCT/US2014/061174 US2014061174W WO2015058103A1 WO 2015058103 A1 WO2015058103 A1 WO 2015058103A1 US 2014061174 W US2014061174 W US 2014061174W WO 2015058103 A1 WO2015058103 A1 WO 2015058103A1
Authority
WO
WIPO (PCT)
Prior art keywords
reaction
volumes
fractionated
reaction component
target
Prior art date
Application number
PCT/US2014/061174
Other languages
French (fr)
Inventor
Dino Di Carlo
Janay KONG
Original Assignee
The Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The University Of California filed Critical The Regents Of The University Of California
Priority to US15/029,231 priority Critical patent/US20160257990A1/en
Publication of WO2015058103A1 publication Critical patent/WO2015058103A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/645Specially adapted constructive features of fluorimeters
    • G01N21/6452Individual samples arranged in a regular 2D-array, e.g. multiwell plates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44756Apparatus specially adapted therefor
    • G01N27/44791Microapparatus

Definitions

  • the technical field generally relates methods and devices used detect the concentration and/or presence of molecules or particles within a sample. More particularly, the invention relates to devices and/or methods in which molecules or particles can be detected with high sensitivity using a modified sandwich enzyme-linked immunosorbent assay (ELISA) that does not require immobilization on a surface or a solid phase.
  • ELISA sandwich enzyme-linked immunosorbent assay
  • the typical sandwich ELISA assay utilizes adsorbed antibodies on a surface that capture antigens or targets and a secondary antibody to provide a detection signal.
  • Others have used beads coupled with femtoliter-sized wells to fractionate the sample and potentially generate a higher sensitivity assay. See Patent Application Publication Nos. 2012/0289428, 2012/0196774).
  • this assay requires one bead per each well, the bead capture efficiency limits the sensitivity of the assay.
  • both traditional and digital ELISAs require a number of wash steps to remove unbound reagents as well as sequential addition of reagents for binding.
  • Another protein/molecule assay that has been developed is the proximity ligation assay. See Patent Application Publication Nos.
  • This assay uses two DNA aptamers or antibodies to detect a protein of interest. These detection probes are functionalized with DNA extension molecules, such that when placed in close proximity of each other, are ligated together. This DNA is then amplified and measured with gel electrophoresis or with fluorescent targeted DNA probes. This technique measures the amount of bulk precipitant generated by the presence of the target analyte.
  • bead-based assays using fractionated sample volumes to generate a binary on/off signal have lower sensitivity because they require a 1 : 1 ratio of beads to wells.
  • the assay contemplated herein does not require a surface or beads and this leads to a higher sensitivity and lower limit of detection.
  • This assay does not require a number of wash steps or sequential addition of reagents, which is typical of current assays. Instead this assay just requires one mix step and then fractionalization.
  • Fractionalization prevents the formation of a false positive signal from components that would otherwise interact in a bulk reaction. While the proximity ligation assay is able to detect proteins with high sensitivity, the bulk measurement technique is more susceptible to noise. Often this technique utilizes a real-time PCR technique that requires multiple thermocycles to achieve a low limit of detection. The gel electrophoresis technique of measuring the amplified DNA requires additional equipment and is costly.
  • the invention relates to devices and/or methods in which molecules or particles can be detected with high sensitivity using a modified sandwich enzyme-linked
  • ELISA immunosorbent assay
  • detection signals can be measured as a binary on/off signal, leading to higher sensitivity.
  • This process is based on the premise that both reaction components (that form the sandwich) need to be in the same fractionated sample volume in order for the reaction to proceed.
  • the affinity of the target molecule or particle to each reaction component brings both components together to initiate a measurable reaction.
  • This method can be used as a clinical diagnostic, including in point of care devices. This technique can also be used in analytical research tools.
  • a method of quantifying the concentration or range of concentration of a target within a sample includes generating a plurality of fractionated volumes, wherein at least some of the fractionated volumes contain the target bound to a first detector molecule connected to a first reaction component (Rl) via a linker molecule, the target also bound to a second detector molecule connected to a second reaction component (R2) via a linker molecule.
  • a reaction is initiated between the first reaction component (Rl) and the second reaction component (R2) within the fractionated volumes.
  • the reaction may occur naturally with the passage of time or an external stimulus such as the application of heat (e.g., increased temperature) or light be needed in some embodiments.
  • the plurality of fractionated volumes is then imaged with an imaging device.
  • a fluorescent probe or other marker is used to identify those fractionated volumes having the target and the reaction components (Rl and R2).
  • the number of fractionated volumes emitting a positive emission signal from the image can be counted using image processing techniques.
  • the concentration or a range of concentrations of the target can then be calculated based at least in part on the number of fractionated volumes emitting a positive emission signal from the image.
  • the number concentration of an initial solution can be estimated by counting the number of volumes with positive emission signals divided by the sample volume that is introduced. Over a concentration range, the concentration is linearly correlated with number of volumes with positive emission signals and calibration with known concentrations can be used to determine the linear coefficient.
  • the molar concentration can be calculated from this number concentration by dividing by Avogadro's number (6.022 x 10 23 ) and converting volume to units of liters. At higher concentrations, a non-continuous gradation in positive emission signal in fractionated volumes can also be used to estimate concentration.
  • a method, of detecting a target within a sample includes generating a plurality of fractionated volumes, wherein at least some of the fractionated volumes contain the target bound to a first detector molecule connected to a first reaction component (Rl), the target also bound to a second detector molecule connected to a second reaction component (R2).
  • a reaction is initiated between the first reaction component (Rl) and the second reaction component (R2) within the fractionated volumes.
  • the plurality of fractionated volumes is then imaged using an imaging device.
  • the fractionated volumes emitting a positive emission signal from the image are then identified using image processing techniques.
  • a microfluidic device in another embodiment, includes an optically transparent substrate and a flexible layer containing a plurality of wells therein, wherein an opening to the plurality of wells faces the substrate and wherein at least one of the flexible layer or the optically transparent substrate is moveable to selectively seal the plurality of wells from each other.
  • FIG. 1 illustrates a target molecule bound to two detector molecules.
  • the two detector molecules are coupled, respectively, to a first reaction component and a second reaction component.
  • FIG. 2 illustrates an alternative embodiment wherein a linker molecule with multiple reaction components is used to speed up the signal amplification reaction.
  • FIG. 3 A illustrates one type of device used to generate the fractional volumes.
  • the device is a droplet-based device whereby droplets are formed containing the assay reaction components and then are collected in a chamber downstream of the droplet formation region. The droplets accumulate within the downstream chamber in a two-dimensional array. The array of droplets within the chamber may then be imaged.
  • FIG. 3B illustrates a magnified view of a portion of the droplet-based device of FIG. 3 A. Illustrated is the intersection of the reaction components with sheath flow inlets that is used to generate the droplets as well as the downstream chamber where the droplets are collected. The two-dimensional array of droplets is illustrated.
  • FIG. 4A illustrates another type of device that is used to generate fractional volumes.
  • This embodiment of the device is a two-layer, compression-based device.
  • An inner volume is formed between the two layers and, when brought together in a compression process, forms a plurality of discrete, fractionated volumes.
  • the fractionated volumes can be formed in an array which may then be imaged.
  • FIG. 4B illustrates a magnified view of a portion of the compression-based device of FIG. 4A.
  • An inlet channel is illustrated that leads the larger region containing a plurality of compartmentalized microwells.
  • Each microwell contains a discrete, fractionated volume in response to compression of the multi-layered device.
  • several of the microwells indicate a "positive" signal that is generated in response to the presence of first and second reaction components (Rl, R2) bound to a target molecule.
  • FIG. 5 A illustrates a side, cross-sectional view of the device of FIGS. 4A and 4B in an uncompressed state.
  • the device includes two layers: a PDMS layer that contains the microwells therein and a glass slide that is brought into facing contact with the PDMS layer.
  • FIG. 5B illustrates a side, cross-sectional view of the device of FIGS. 4A and 4B in a compressed state. The device is interposed between two compression plates that are squeezed together to compress the glass slide against the PDMS layer to form the separate micro wells.
  • FIG. 5C illustrates an alternative embodiment of a compression device.
  • FIG. 6 illustrates an imaging device used in connection with the microfluidic device according to one embodiment.
  • FIG. 7A illustrates imaged microwells of the device of FIGS. 4A and 4B.
  • Fluorescent dye (fluorescein) is contained in the microwells which are then imaged with an imaging device.
  • FIG. 7B illustrates a magnified view of FIG. 7A.
  • FIG. 8 illustrate DNA electrophoresis gel results illustrating that the LAMP amplification reaction for the entire ⁇ DNA as well as the shortened 600bp and lOOObp ⁇ DNA.
  • FIG. 9 illustrates a panel of images taken of a device of the embodiment of FIGS. 4A and 4B at times zero (0) and sixty minutes (60) for a control (0 DNA), 600 bp ⁇ DNA, and lk bp ⁇ DNA.
  • the ⁇ DNA samples were diluted lOOx in mixed with LAMP reagents in 20 ⁇ well devices.
  • FIG. 1 illustrates the detection mechanism employed in one embodiment.
  • the detection mechanism involves a target 10 which may include a molecule, molecules, or larger particle of interest.
  • the target 10 may include a living particle such as a cell in some embodiments.
  • the detection scheme includes a first detector molecule 12 and a second detector molecule 14.
  • the detector molecules 12, 14 may be the same or different.
  • the detector molecules 12, 14 are an antibody or aptamer with an affinity to the target 10.
  • the target 10 may include a protein molecule and the first detector molecule 12 and the second detector molecule 14 may include an antibody or aptamer with an affinity to the protein molecule.
  • the target 10 has two or more binding sites that bind to the detector molecules 12, 14.
  • a linker molecule 16 is conjugated to the first detector molecule 12.
  • the linker molecule 16 is typically a long, flexible molecule that connects the first detector molecule 12 to a corresponding reaction component (described in more detail below).
  • the linker molecule 16 may include a polyethylene glycol oligomer, for example.
  • the linker molecule 16 is conjugated at the other end to a first reaction component Rl as illustrated in FIG. 1.
  • a second reaction component R2 is conjugated directly to the second detector molecule 14.
  • a linker molecule 16 may be conjugated at one end or region to the second detector molecule 14 and at the other end or region to the second reaction component R2.
  • the linker molecule 16 that connects to the second detector molecule 14 may be the same as, or different from, the linker molecule 16 that is connected to the first detector molecule 12.
  • a key aspect of the linker molecule 16 is that it allows for sufficient motion of a reaction component and is of sufficient length to allow for spatial contact between first and second reaction components (Rl, R2) to aid in the progression of the reaction.
  • the linker molecules 16 may be joined with the associated detector molecules 12, 14 and reaction components Rl, R2 via any number of bonds including covalent, ionic, electrostatic, and the like.
  • the first reaction component Rl is an enzyme, such as DNA polymerase or several DNA polymerases while the second reaction component R2 is a DNA sequence (single strand or multiple strands).
  • R2 may be a single stranded DNA sequence that is used as part of an amplification reaction such as loop-mediated isothermal amplification.
  • the output of the reaction is then converted to an optical signal, for example, by using double-stranded DNA intercalation dye fluorescence (e.g., SYBR® dyes).
  • the first reaction component Rl may be an enzyme while second reaction component R2 includes a fluorogenic substrate or multiple fluorogenic substrates.
  • the enzyme e.g., carboxylesterase
  • the signal may be amplified and detected.
  • the first and second detector molecules 12, 14, such as antibodies, are conjugated directly or indirectly through a linker 16 to first and second reaction components Rl, R2. Only when both detector molecules 12, 14 are attached to the target analyte 10 will a "sandwich" be formed, bringing the first reaction component Rl and the second reaction component R2 together as shown in FIG. 1. The presence of the target 10 and the bound detector molecules 12, 14 brings both reaction components Rl, R2 into the same fractionated volume 18, initiating the reaction and generating a positive signal.
  • temperature adjustment or the application of light can be used following fractionation to initiate the reaction (e.g. a temperature increase for loop-mediated isothermal amplification).
  • Fractionated volume 18 refers to a geographically discrete area of a testing device 10, 40.
  • the reaction that generates a positive signal may include, in one embodiment, nucleic acid amplification.
  • the reaction may include, for example, an enzyme-mediated reaction to form fluorescent compounds from fluorogenic substrates or species.
  • a dye is used to generate an optical signal by intercalation with the nucleic acid that then fluoresces in response to illumination with excitation light. In some embodiments, where fluorogenic substrates are used, no such dye is needed. Without the presence of the target 10, the levels of both detector molecules 12, 14 are low enough that the probability of being in the same fractionated sample volume is also low, leading to a low and predictable number of fractionated or segregated areas with a background positive signal.
  • FIG. 2 illustrates an alternative detection configuration whereby a linker 16 is connected with multiple first reaction components Rl .
  • the multiple reaction sites allow for quicker reaction progression to achieve sufficient signal for fluorescence or colorimetric detection in a shorter time period.
  • the linker 16 maybe a branched structure to aid in providing multiple reaction sites. While FIG. 2 illustrates multiple first reaction components Rl it should be understood that multiple second reaction components R2 could also be provided.
  • FIG. 3 A illustrates one type of device 20 used to generate the fractional volumes 18 (illustrated in FIGS. 3B).
  • the device 20 is a microfluidic device that generates micro-emulsions (i.e., droplets 22) that act as the fractional volumes 18.
  • the droplets may have a variety of diameters but are typically greater than 10 ⁇ .
  • the device 20 includes a first inlet 24 that is used to deliver a sample with the target 10 as well as the reaction mixture that contains the first detector molecule 12 (and associated first reaction component Rl) and the second detector molecule 14 (and the second reaction component R2).
  • this fluid is an aqueous fluid.
  • a second inlet 26 is provided that can be used to deliver a fluid that is immiscible with the fluid delivered via the first inlet 24.
  • a fluid that is immiscible with the fluid delivered via the first inlet 24.
  • an oil-based fluid may be delivered to the second inlet 26.
  • Fluid may be delivered to the first inlet 24 and second inlet 26 via respective fluid pumps (e.g., syringe pumps or the like; not shown).
  • a channel 28 coupled to the first inlet 24 and intersects with two opposing channels 30 connected to the second inlet 26. The intersection of the channels 28, 30 forms a droplet generation region 32 whereby the aqueous droplets 22 are pinched off using a sheath flow from the opposing channels 30.
  • Another channel 34 connects the droplet generation region 32 to a downstream droplet collection region 36.
  • the droplet collection region 36 is a three dimensional chamber with a large width and length but small height so that droplets 22 form a two-dimensional array within the droplet collection region 36.
  • the droplet collection region 36 is constructed with a height so that the droplets 22 do not stack in multiple layers which would interfere with the imaging of the discrete fractional volumes 18 which is needed for detection and concentration determination.
  • the droplet collection region 36 is coupled via channel 38 to an outlet 40 whereby the droplets 22 fluids and like can be removed from the device 20.
  • FIG. 3B illustrates a magnified view of the droplet generation region 32 and the downstream droplet collection region 36.
  • Reaction components including the detector molecules 12, 14 and their respective reaction components Rl, R2 are illustrated within channel 28.
  • Droplets are pinched off in the droplet generation region 32 and collected in the droplet collection region 36.
  • Certain droplets 22' contained within the droplet generation region 32 exhibit a positive optical signal because they contain the target 10 and detector molecules 12, 14 (with associated reaction components Rl, R2).
  • the optical signal is binary in that each droplet either emits a positive optical signal or not in this case.
  • reaction components Rl and R2 have less probability to interact in a random fashion but react more commonly when bound to the target 10 and therefore can be present within the same fractional volume 18 at higher levels than Poisson statistics would dictate. Fractionalization also allows for a diffusible signal to accumulate to higher levels that can be more easily interrogated - another critical component of the invention.
  • FIG. 4A illustrates another embodiment of a device 40.
  • the fractional volumes 18 are created using a plurality of discrete microwells 46 which are formed in the device 40. Some of the microwells 46' contain fractional volumes 18 that are positive in that first and second reaction components Rl, R2 bind to a target 10 and emit a positive optical signal.
  • the device 40 includes an inlet 42 that is fluidically connected to a region 44 holding a plurality of microwells 46.
  • the microwells 46 are formed in a flexible layer 48 (FIGS. 5A-5C) which may include a flexible substrate such as polydimethylsiloxane (PDMS).
  • PDMS polydimethylsiloxane
  • Each microwell 46 forms a fractional volume 18 such that when the device 40 is fully assembled and loaded with fluid forms a discrete, separate reaction volume.
  • the size of the microwells 46 may vary but microwells 46 having a width of around 15 ⁇ and height greater than or equal to 60 ⁇ are preferred. The larger the total volume of confined regions the lower the detection limit for the assay.
  • the device 40 further includes an outlet 50 whereby fluids can be removed from the device 40.
  • the device 40 is a two-layer device that is formed from by compressing the flexible layer 48 containing the microwells 46 against an optically transparent substrate 52.
  • the optically transparent substrate 52 may include a glass slide although other optically transparent materials may be used (e.g., plastics, etc.).
  • the two-layer device 40 is filled with the mixed assay components that include the target 10 and detector molecules 12, 14 (with associate reaction components Rl, R2) until all the microwells 46 are filled and all dead volume is gone. There exists a small height in all areas outside the microwells 46 to ensure complete fractionalization once the device 40 is compressed.
  • FIG. 5A illustrates a side view of the device 40 in an uncompressed state.
  • a thin layer of fluid is seen interposed between the upper surface of the microwells 46 and the opposing optically transparent substrate 52. There exists a gap or height in this state whereby fluid containing the mixed assay components can be introduced into the microwells 46.
  • the fluid may be delivered to the device via the inlet 42 and removed from the device from the outlet 50. In one embodiment, only the inlet 42 is needed given that dead volume gas is able to exit the device via the flexible layer 48 (e.g., gas permeable PDMS layer).
  • the flexible layer 48 e.g., gas permeable PDMS layer
  • a compression device 54 is used to compress the flexible layer 48 and the optically transparent substrate 52 together.
  • the compression device 54 in FIG. 5B includes compression plates 56 that press against the flexible layer 48 and the optically transparent substrate 52. Threaded screws 58 passing through the compression plates 56 have nuts 60 that can be tightened to compress the flexible layer 48 and the optically transparent substrate 52.
  • FIG. 5C illustrates an alternative embodiment of a compression device 54 that uses a housing 55 with a single compression plate 56 that is operated by a screw 57. Note that in the embodiment of FIG. 5B, the housing 55 should still provide access to view and image the region 44 containing the microwells 46. Thus, the housing 55 (or compression plates 56 for the embodiment of FIG.
  • FIG. 5B illustrate the device 40 in the compressed state whereby there no longer is the thin layer of fluid between the flexible layer 48 and the optically transparent substrate 52 together.
  • the devices 20, 40 may be patterned using photolithography, and then prototyped using PDMS or other materials used for micro fluidic devices. Alternatively, this can also be made using epoxy or using an injection molding process. In the embodiment that uses device 40, the flexible layer 48 needs to have some degree of flexibility to form the fractional volumes 18 during the compression operation.
  • a sample that is known or believed to contain the target 10 is mixed with metered concentrations of both reaction component assemblies (i.e., the detector molecules 12, 14 with associated reaction components Rl, R2 in stoichiometric excess required for reaction and then flowed through the device 20, 40 to create fractionated volumes 18.
  • the reaction is then proceeds or is initiated (e.g., by passage of time, change in temperature, exposure to light, etc.), and an optical response is measured using an imaging device 70 as illustrated in FIG. 6.
  • FIG. 6 illustrates an imaging device 70 according to one embodiment.
  • the imaging device 70 includes an excitation light source 72 that is used to illuminate the region of the device 20, 40 that contains the fractional volumes 18.
  • the excitation light source 72 may include an emission filter as is known in the art so that the device 20, 40 is illuminated at the wavelength range that causes the fluorescent probe or dye to fluoresce.
  • the imaging device 70 includes an imager 74 that captures images of the region of the device 20, 40 that contains the fractional volumes 18.
  • the imager 74 may include a microscope with an attached camera or it may include a solid state imaging device such as a CCD or CMOS image sensor.
  • the imager 74 may also be a small portable imaging device that may be used in connection with a mobile communication device such as a mobile phone.
  • FIG. 6 also illustrates a heater 78 that, in some embodiments, may be needed to heat the fractional volumes 18 to promote or accelerate reaction.
  • the heater 78 may include a thermoresistive heater or other similar device.
  • the heater 78 may be controlled through a controller (not shown) or through computer 80.
  • the computer 80 in FIG. 6 contains at least one processor 82 therein and runs imaging software. Image frames obtained from the imager 74 can be transferred or otherwise accessed by the computer 80 for image processing.
  • the computer 80 may include a display 84 that is used to display, for example, the 2D array of fractional volumes 18.
  • the display 84 may illustrate the positive fractional volumes 18 that are detected in the device 20, 40.
  • the display 84 may also display a concentration or concentration range that is based in part on the number of positive fractional volumes 18 that are observed in the device 20, 40.
  • Image software such as ImageJ software that is executed by the processor 82 using computer 80 may be used to detect and quantify fluorescently labeled fractional volumes 18.
  • the software may perform background subtractions and contrast enhancement.
  • FIGS. 7A and 7B illustrates two images (at different magnifications) of the microwells 46 of the device 40 of FIGS. 4A and 4B. Fluorescent dye (fluorescein) is contained in the microwells 46 which are then imaged with an imaging device 70.
  • Fluorescent dye fluorescein
  • the concentration or a range of concentrations of the target 10 can then be calculated based at least in part on the number of fractionated volumes 18 emitting a positive emission signal from the image.
  • the number concentration of an initial solution can be estimated by counting the number of fractionated volumes 18 with positive emission signals divided by the sample volume introduced. Over a concentration range described in Tables 1 and 2, concentration is linearly correlated with number of volumes with positive emission signals and calibration with known concentrations can be used to determine the linear coefficient of correlation.
  • the molar concentration can be calculated from this number concentration by dividing by Avogadro's number (6.022 x 10 23 ) and converting volume to units of liters.
  • a non-continuous gradation in positive emission signal in fractionated volumes can also be used to estimate concentration as described in Rissin et al, simultaneous detection of single molecules and singulated ensembles of molecules enables immunoassays with broad dynamic range, Anal Chem. 2011 Mar 15;83(6):2279-85, which is incorporated by reference as if set forth fully herein.
  • first reaction component Rl is an enzyme, such as DNA polymerase or several DNA polymerases while the second reaction component R2 is a DNA sequence (single strand or multiple strands).
  • the experiment utilized loop-mediated isothermal amplification (LAMP) which is an amplification method that amplifies DNA under isothermal conditions using a set of four specialty designed primers and DNA polymerase. Details regarding the LAMP process may be found in Nagamine et al, Accelerated reaction by loop-mediated isothermal amplification using loop primers, Molecular and Cellular Probes, 16, 223-229 (2002), which is
  • the shortened sequences included a 600 bp shortened sequence of ⁇ DNA (SEQ ID NO:7) and a lk shortened sequence of ⁇ DNA (SEQ ID NO:8).
  • the LAMP reaction was run with 25 ⁇ ⁇ of a 2x reaction mix containing 2M betaine, 40mM Tris-HCL (pH 8.8), 20 mM KCL, 20 mM (NH 4 ) 2 S0 4 , 12 mM MgS0 4 , 0.2% Triton-X 100, and 3.2 mM dNTPs in combination with DNA, primer mix, SYBR green, DNA polymerase, and water. 5 ⁇ ⁇ of DNA (5.74 x 10 10 copies/ ⁇ ) was used with 2 ⁇ ⁇ of the primer mix.
  • the primer mix included 16 ⁇ FIP, 16 ⁇ BIP, 2 ⁇ F3, 2 ⁇ B3, 4 ⁇ Loop F, and 4 ⁇ Loop B.
  • FIG. 8 illustrate DNA electrophoresis gel results illustrating that the LAMP amplification reaction for the entire ⁇ DNA as well as the shortened 600bp and lOOObp ⁇ DNA. All LAMP materials were mixed together on ice and incubated at 65°C for one hour.
  • FIG. 9 illustrates fluorescent images obtained of the device of FIGS. 4A and 4B after the addition of lOOx diluted DNA. In this experiment, all of the LAMP reaction components were mixed together on ice and the device was filled and then compressed. The device was incubated at 65 °C for one hour. The device was then imaged with fluorescein isothiocyanate (FITC) filter set to detect SYBR green fluorescence of double stranded DNA.
  • FITC fluorescein isothiocyanate
  • the device has microwells with diameters of 20 ⁇ and height of 60 ⁇ . Both the zero (0) DNA and initial time zero (0) conditions illustrate a low signal to noise ratio (because of the expected low signal).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

A method of detecting a target and quantifying the concentration of the same within a sample includes generating a plurality of fractionated volumes, wherein at least some of the fractionated volumes contain the target bound to a first detector molecule connected to a first reaction component (R1) and a second detector molecule connected to a second reaction component (R2). The fractionated volumes that contain the target, first detector molecule, second detector molecule, and a probe or other reporter molecule emit light and are imaged. Fractionated volumes emitting radiation can be used to detect the presence of the target within the sample. The number of fractionated volumes emitting a positive emission signal can be counted from the image and the concentration (or range of calculations) of the target can be calculated based at least in part on the number of fractionated volumes emitting a positive emission signal from the image.

Description

METHOD AND DEVICE FOR DETECTING MOLECULES OR PARTICLES
USING FRACTIONALIZED VOLUMES
Related Application
[0001] This Application claims priority to U.S. Provisional Patent Application No.
61/892,932 filed on October 18, 2013, which is hereby incorporated by reference in its entirety. Priority is claimed pursuant to 35 U.S.C. § 1 19.
Statement Regarding Federally Sponsored
Research and Development
[0002] This invention was made with Government support under award no. 1332275 awarded by the National Science Foundation (EDISON). The Government has certain rights in the invention.
Field of the Invention
[0003] The technical field generally relates methods and devices used detect the concentration and/or presence of molecules or particles within a sample. More particularly, the invention relates to devices and/or methods in which molecules or particles can be detected with high sensitivity using a modified sandwich enzyme-linked immunosorbent assay (ELISA) that does not require immobilization on a surface or a solid phase.
Background
[0004] The typical sandwich ELISA assay utilizes adsorbed antibodies on a surface that capture antigens or targets and a secondary antibody to provide a detection signal. Others have used beads coupled with femtoliter-sized wells to fractionate the sample and potentially generate a higher sensitivity assay. See Patent Application Publication Nos. 2012/0289428, 2012/0196774). However, since this assay requires one bead per each well, the bead capture efficiency limits the sensitivity of the assay. Additionally, both traditional and digital ELISAs require a number of wash steps to remove unbound reagents as well as sequential addition of reagents for binding. Another protein/molecule assay that has been developed is the proximity ligation assay. See Patent Application Publication Nos. 2008/0090238, 2008/0293051). This assay uses two DNA aptamers or antibodies to detect a protein of interest. These detection probes are functionalized with DNA extension molecules, such that when placed in close proximity of each other, are ligated together. This DNA is then amplified and measured with gel electrophoresis or with fluorescent targeted DNA probes. This technique measures the amount of bulk precipitant generated by the presence of the target analyte.
[0005] Existing assays require detection antibodies to be immobilized on a surface, including bead-based assays. The assay contemplated herein does not need to be
immobilized on a surface for sensitive molecule detection, thus saving cost of materials. Additionally, bead-based assays using fractionated sample volumes to generate a binary on/off signal have lower sensitivity because they require a 1 : 1 ratio of beads to wells. Thus, in contrast to bead or surface-based assays, the assay contemplated herein does not require a surface or beads and this leads to a higher sensitivity and lower limit of detection. This assay does not require a number of wash steps or sequential addition of reagents, which is typical of current assays. Instead this assay just requires one mix step and then fractionalization.
Fractionalization prevents the formation of a false positive signal from components that would otherwise interact in a bulk reaction. While the proximity ligation assay is able to detect proteins with high sensitivity, the bulk measurement technique is more susceptible to noise. Often this technique utilizes a real-time PCR technique that requires multiple thermocycles to achieve a low limit of detection. The gel electrophoresis technique of measuring the amplified DNA requires additional equipment and is costly.
Summary
[0006] The invention relates to devices and/or methods in which molecules or particles can be detected with high sensitivity using a modified sandwich enzyme-linked
immunosorbent assay (ELISA) that does not require immobilization on a surface or a solid phase. Using fractionated or segmented volumes, detection signals can be measured as a binary on/off signal, leading to higher sensitivity. This process is based on the premise that both reaction components (that form the sandwich) need to be in the same fractionated sample volume in order for the reaction to proceed. The affinity of the target molecule or particle to each reaction component brings both components together to initiate a measurable reaction. This method can be used as a clinical diagnostic, including in point of care devices. This technique can also be used in analytical research tools.
[0007] In one aspect of the invention, a method of quantifying the concentration or range of concentration of a target within a sample includes generating a plurality of fractionated volumes, wherein at least some of the fractionated volumes contain the target bound to a first detector molecule connected to a first reaction component (Rl) via a linker molecule, the target also bound to a second detector molecule connected to a second reaction component (R2) via a linker molecule. A reaction is initiated between the first reaction component (Rl) and the second reaction component (R2) within the fractionated volumes. The reaction may occur naturally with the passage of time or an external stimulus such as the application of heat (e.g., increased temperature) or light be needed in some embodiments. The plurality of fractionated volumes is then imaged with an imaging device. Typically, a fluorescent probe or other marker is used to identify those fractionated volumes having the target and the reaction components (Rl and R2). The number of fractionated volumes emitting a positive emission signal from the image can be counted using image processing techniques. The concentration or a range of concentrations of the target can then be calculated based at least in part on the number of fractionated volumes emitting a positive emission signal from the image. The number concentration of an initial solution can be estimated by counting the number of volumes with positive emission signals divided by the sample volume that is introduced. Over a concentration range, the concentration is linearly correlated with number of volumes with positive emission signals and calibration with known concentrations can be used to determine the linear coefficient. The molar concentration can be calculated from this number concentration by dividing by Avogadro's number (6.022 x 1023) and converting volume to units of liters. At higher concentrations, a non-continuous gradation in positive emission signal in fractionated volumes can also be used to estimate concentration.
[0008] In another embodiment, a method, of detecting a target within a sample includes generating a plurality of fractionated volumes, wherein at least some of the fractionated volumes contain the target bound to a first detector molecule connected to a first reaction component (Rl), the target also bound to a second detector molecule connected to a second reaction component (R2). A reaction is initiated between the first reaction component (Rl) and the second reaction component (R2) within the fractionated volumes. The plurality of fractionated volumes is then imaged using an imaging device. The fractionated volumes emitting a positive emission signal from the image are then identified using image processing techniques.
[0009] In another embodiment, a microfluidic device includes an optically transparent substrate and a flexible layer containing a plurality of wells therein, wherein an opening to the plurality of wells faces the substrate and wherein at least one of the flexible layer or the optically transparent substrate is moveable to selectively seal the plurality of wells from each other.
Brief Description of the Drawings
[0010] FIG. 1 illustrates a target molecule bound to two detector molecules. The two detector molecules are coupled, respectively, to a first reaction component and a second reaction component.
[001 1] FIG. 2 illustrates an alternative embodiment wherein a linker molecule with multiple reaction components is used to speed up the signal amplification reaction.
[0012] FIG. 3 A illustrates one type of device used to generate the fractional volumes. The device is a droplet-based device whereby droplets are formed containing the assay reaction components and then are collected in a chamber downstream of the droplet formation region. The droplets accumulate within the downstream chamber in a two-dimensional array. The array of droplets within the chamber may then be imaged.
[0013] FIG. 3B illustrates a magnified view of a portion of the droplet-based device of FIG. 3 A. Illustrated is the intersection of the reaction components with sheath flow inlets that is used to generate the droplets as well as the downstream chamber where the droplets are collected. The two-dimensional array of droplets is illustrated.
[0014] FIG. 4A illustrates another type of device that is used to generate fractional volumes. This embodiment of the device is a two-layer, compression-based device. An inner volume is formed between the two layers and, when brought together in a compression process, forms a plurality of discrete, fractionated volumes. The fractionated volumes can be formed in an array which may then be imaged.
[0015] FIG. 4B illustrates a magnified view of a portion of the compression-based device of FIG. 4A. An inlet channel is illustrated that leads the larger region containing a plurality of compartmentalized microwells. Each microwell contains a discrete, fractionated volume in response to compression of the multi-layered device. In FIG. 4B, several of the microwells indicate a "positive" signal that is generated in response to the presence of first and second reaction components (Rl, R2) bound to a target molecule.
[0016] FIG. 5 A illustrates a side, cross-sectional view of the device of FIGS. 4A and 4B in an uncompressed state. The device includes two layers: a PDMS layer that contains the microwells therein and a glass slide that is brought into facing contact with the PDMS layer. [0017] FIG. 5B illustrates a side, cross-sectional view of the device of FIGS. 4A and 4B in a compressed state. The device is interposed between two compression plates that are squeezed together to compress the glass slide against the PDMS layer to form the separate micro wells.
[0018] FIG. 5C illustrates an alternative embodiment of a compression device.
[0019] FIG. 6 illustrates an imaging device used in connection with the microfluidic device according to one embodiment.
[0020] FIG. 7A illustrates imaged microwells of the device of FIGS. 4A and 4B.
Fluorescent dye (fluorescein) is contained in the microwells which are then imaged with an imaging device.
[0021 ] FIG. 7B illustrates a magnified view of FIG. 7A.
[0022] FIG. 8 illustrate DNA electrophoresis gel results illustrating that the LAMP amplification reaction for the entire λ DNA as well as the shortened 600bp and lOOObp λ DNA.
[0023] FIG. 9 illustrates a panel of images taken of a device of the embodiment of FIGS. 4A and 4B at times zero (0) and sixty minutes (60) for a control (0 DNA), 600 bp λ DNA, and lk bp λ DNA. The λ DNA samples were diluted lOOx in mixed with LAMP reagents in 20 μιη well devices.
Detailed Description of the Illustrated Embodiments
[0024] FIG. 1 illustrates the detection mechanism employed in one embodiment. The detection mechanism involves a target 10 which may include a molecule, molecules, or larger particle of interest. The target 10 may include a living particle such as a cell in some embodiments. The detection scheme includes a first detector molecule 12 and a second detector molecule 14. The detector molecules 12, 14 may be the same or different.
Typically, the detector molecules 12, 14 are an antibody or aptamer with an affinity to the target 10. For example, the target 10 may include a protein molecule and the first detector molecule 12 and the second detector molecule 14 may include an antibody or aptamer with an affinity to the protein molecule. The target 10 has two or more binding sites that bind to the detector molecules 12, 14. Still referring to FIG. 1, a linker molecule 16 is conjugated to the first detector molecule 12. The linker molecule 16 is typically a long, flexible molecule that connects the first detector molecule 12 to a corresponding reaction component (described in more detail below). The linker molecule 16 may include a polyethylene glycol oligomer, for example. The linker molecule 16 is conjugated at the other end to a first reaction component Rl as illustrated in FIG. 1.
[0025] With reference to FIG. 1, a second reaction component R2 is conjugated directly to the second detector molecule 14. Optionally, a linker molecule 16 may be conjugated at one end or region to the second detector molecule 14 and at the other end or region to the second reaction component R2. In this optional embodiment, the linker molecule 16 that connects to the second detector molecule 14 may be the same as, or different from, the linker molecule 16 that is connected to the first detector molecule 12. A key aspect of the linker molecule 16 is that it allows for sufficient motion of a reaction component and is of sufficient length to allow for spatial contact between first and second reaction components (Rl, R2) to aid in the progression of the reaction. The linker molecules 16 may be joined with the associated detector molecules 12, 14 and reaction components Rl, R2 via any number of bonds including covalent, ionic, electrostatic, and the like.
[0026] In one embodiment, the first reaction component Rl is an enzyme, such as DNA polymerase or several DNA polymerases while the second reaction component R2 is a DNA sequence (single strand or multiple strands). For example, R2 may be a single stranded DNA sequence that is used as part of an amplification reaction such as loop-mediated isothermal amplification. The output of the reaction is then converted to an optical signal, for example, by using double-stranded DNA intercalation dye fluorescence (e.g., SYBR® dyes). In another embodiment, the first reaction component Rl may be an enzyme while second reaction component R2 includes a fluorogenic substrate or multiple fluorogenic substrates. In this embodiment, the enzyme (e.g., carboxylesterase) may turnover fluorophores from the fluorogenic substrate(s) (e.g., fluorescein diacetate) to generate a fluorescent signal.
Generally, it is preferable to have multiple reaction sites so that the signal may be amplified and detected.
[0027] In order to detect a target 10 of interest, the first and second detector molecules 12, 14, such as antibodies, are conjugated directly or indirectly through a linker 16 to first and second reaction components Rl, R2. Only when both detector molecules 12, 14 are attached to the target analyte 10 will a "sandwich" be formed, bringing the first reaction component Rl and the second reaction component R2 together as shown in FIG. 1. The presence of the target 10 and the bound detector molecules 12, 14 brings both reaction components Rl, R2 into the same fractionated volume 18, initiating the reaction and generating a positive signal. Alternatively, temperature adjustment or the application of light can be used following fractionation to initiate the reaction (e.g. a temperature increase for loop-mediated isothermal amplification). This approach prevents pre-mature reaction of Rl and R2 prior to fractionation which would lead to a higher background signal. Fractionated volume 18 refers to a geographically discrete area of a testing device 10, 40. The reaction that generates a positive signal may include, in one embodiment, nucleic acid amplification. In another embodiment, the reaction may include, for example, an enzyme-mediated reaction to form fluorescent compounds from fluorogenic substrates or species. For some reactions, such as nucleic acid amplification, a dye is used to generate an optical signal by intercalation with the nucleic acid that then fluoresces in response to illumination with excitation light. In some embodiments, where fluorogenic substrates are used, no such dye is needed. Without the presence of the target 10, the levels of both detector molecules 12, 14 are low enough that the probability of being in the same fractionated sample volume is also low, leading to a low and predictable number of fractionated or segregated areas with a background positive signal.
[0028] FIG. 2 illustrates an alternative detection configuration whereby a linker 16 is connected with multiple first reaction components Rl . The multiple reaction sites allow for quicker reaction progression to achieve sufficient signal for fluorescence or colorimetric detection in a shorter time period. As seen in FIG. 2, there are eight (8) copies of reaction component Rl. The linker 16 maybe a branched structure to aid in providing multiple reaction sites. While FIG. 2 illustrates multiple first reaction components Rl it should be understood that multiple second reaction components R2 could also be provided.
[0029] FIG. 3 A illustrates one type of device 20 used to generate the fractional volumes 18 (illustrated in FIGS. 3B). In this embodiment, the device 20 is a microfluidic device that generates micro-emulsions (i.e., droplets 22) that act as the fractional volumes 18. The droplets may have a variety of diameters but are typically greater than 10 μιη. The device 20 includes a first inlet 24 that is used to deliver a sample with the target 10 as well as the reaction mixture that contains the first detector molecule 12 (and associated first reaction component Rl) and the second detector molecule 14 (and the second reaction component R2). Typically, this fluid is an aqueous fluid. A second inlet 26 is provided that can be used to deliver a fluid that is immiscible with the fluid delivered via the first inlet 24. For example, an oil-based fluid may be delivered to the second inlet 26. Fluid may be delivered to the first inlet 24 and second inlet 26 via respective fluid pumps (e.g., syringe pumps or the like; not shown). A channel 28 coupled to the first inlet 24 and intersects with two opposing channels 30 connected to the second inlet 26. The intersection of the channels 28, 30 forms a droplet generation region 32 whereby the aqueous droplets 22 are pinched off using a sheath flow from the opposing channels 30. Another channel 34 connects the droplet generation region 32 to a downstream droplet collection region 36. The droplet collection region 36 is a three dimensional chamber with a large width and length but small height so that droplets 22 form a two-dimensional array within the droplet collection region 36. The droplet collection region 36 is constructed with a height so that the droplets 22 do not stack in multiple layers which would interfere with the imaging of the discrete fractional volumes 18 which is needed for detection and concentration determination. The droplet collection region 36 is coupled via channel 38 to an outlet 40 whereby the droplets 22 fluids and like can be removed from the device 20.
[0030] FIG. 3B illustrates a magnified view of the droplet generation region 32 and the downstream droplet collection region 36. Reaction components including the detector molecules 12, 14 and their respective reaction components Rl, R2 are illustrated within channel 28. Droplets are pinched off in the droplet generation region 32 and collected in the droplet collection region 36. Certain droplets 22' contained within the droplet generation region 32 exhibit a positive optical signal because they contain the target 10 and detector molecules 12, 14 (with associated reaction components Rl, R2). The optical signal is binary in that each droplet either emits a positive optical signal or not in this case. The invention requires that reactions are compartmentalized such that reaction components Rl and R2 have less probability to interact in a random fashion but react more commonly when bound to the target 10 and therefore can be present within the same fractional volume 18 at higher levels than Poisson statistics would dictate. Fractionalization also allows for a diffusible signal to accumulate to higher levels that can be more easily interrogated - another critical component of the invention.
[0031] FIG. 4A illustrates another embodiment of a device 40. In this embodiment, the fractional volumes 18 (as seen in FIG. 4B) are created using a plurality of discrete microwells 46 which are formed in the device 40. Some of the microwells 46' contain fractional volumes 18 that are positive in that first and second reaction components Rl, R2 bind to a target 10 and emit a positive optical signal. With reference to FIGS. 4A, the device 40 includes an inlet 42 that is fluidically connected to a region 44 holding a plurality of microwells 46. The microwells 46 are formed in a flexible layer 48 (FIGS. 5A-5C) which may include a flexible substrate such as polydimethylsiloxane (PDMS). Each microwell 46 forms a fractional volume 18 such that when the device 40 is fully assembled and loaded with fluid forms a discrete, separate reaction volume. The size of the microwells 46 may vary but microwells 46 having a width of around 15 μιη and height greater than or equal to 60 μιη are preferred. The larger the total volume of confined regions the lower the detection limit for the assay. The device 40 further includes an outlet 50 whereby fluids can be removed from the device 40. With reference to FIGS. 5A and 5B, the device 40 is a two-layer device that is formed from by compressing the flexible layer 48 containing the microwells 46 against an optically transparent substrate 52. The optically transparent substrate 52 may include a glass slide although other optically transparent materials may be used (e.g., plastics, etc.). During use, the two-layer device 40 is filled with the mixed assay components that include the target 10 and detector molecules 12, 14 (with associate reaction components Rl, R2) until all the microwells 46 are filled and all dead volume is gone. There exists a small height in all areas outside the microwells 46 to ensure complete fractionalization once the device 40 is compressed.
[0032] FIG. 5A illustrates a side view of the device 40 in an uncompressed state. A thin layer of fluid is seen interposed between the upper surface of the microwells 46 and the opposing optically transparent substrate 52. There exists a gap or height in this state whereby fluid containing the mixed assay components can be introduced into the microwells 46. The fluid may be delivered to the device via the inlet 42 and removed from the device from the outlet 50. In one embodiment, only the inlet 42 is needed given that dead volume gas is able to exit the device via the flexible layer 48 (e.g., gas permeable PDMS layer).
[0033] With reference to FIG. 5B, a compression device 54 is used to compress the flexible layer 48 and the optically transparent substrate 52 together. The compression device 54 in FIG. 5B includes compression plates 56 that press against the flexible layer 48 and the optically transparent substrate 52. Threaded screws 58 passing through the compression plates 56 have nuts 60 that can be tightened to compress the flexible layer 48 and the optically transparent substrate 52. FIG. 5C illustrates an alternative embodiment of a compression device 54 that uses a housing 55 with a single compression plate 56 that is operated by a screw 57. Note that in the embodiment of FIG. 5B, the housing 55 should still provide access to view and image the region 44 containing the microwells 46. Thus, the housing 55 (or compression plates 56 for the embodiment of FIG. 5B) may press on regions of the flexible layer 48 and the optically transparent substrate 52 that do not overlie the region 44. Alternatively, the compression plates 56 may be optically transparent themselves. FIG. 5B illustrate the device 40 in the compressed state whereby there no longer is the thin layer of fluid between the flexible layer 48 and the optically transparent substrate 52 together.
Instead, the fluid is trapped within the microwells 46 that have become discrete fractional volumes 18 that are separated from one another. [0034] The devices 20, 40 may be patterned using photolithography, and then prototyped using PDMS or other materials used for micro fluidic devices. Alternatively, this can also be made using epoxy or using an injection molding process. In the embodiment that uses device 40, the flexible layer 48 needs to have some degree of flexibility to form the fractional volumes 18 during the compression operation.
[0035] During use, a sample that is known or believed to contain the target 10 is mixed with metered concentrations of both reaction component assemblies (i.e., the detector molecules 12, 14 with associated reaction components Rl, R2 in stoichiometric excess required for reaction and then flowed through the device 20, 40 to create fractionated volumes 18. The reaction is then proceeds or is initiated (e.g., by passage of time, change in temperature, exposure to light, etc.), and an optical response is measured using an imaging device 70 as illustrated in FIG. 6.
[0036] FIG. 6 illustrates an imaging device 70 according to one embodiment. The imaging device 70 includes an excitation light source 72 that is used to illuminate the region of the device 20, 40 that contains the fractional volumes 18. The excitation light source 72 may include an emission filter as is known in the art so that the device 20, 40 is illuminated at the wavelength range that causes the fluorescent probe or dye to fluoresce. The imaging device 70 includes an imager 74 that captures images of the region of the device 20, 40 that contains the fractional volumes 18. The imager 74 may include a microscope with an attached camera or it may include a solid state imaging device such as a CCD or CMOS image sensor. The imager 74 may also be a small portable imaging device that may be used in connection with a mobile communication device such as a mobile phone. An example of such a system is disclosed in U.S. Patent Application Publication No. 2012/0157160 which is incorporated by reference as if set forth fully herein. A filter 76 may be used so that only fluorescent light is being imaged by the imager 74. As seen in FIG. 6, the device 20, 40 is held atop a support 76. FIG. 6 also illustrates a heater 78 that, in some embodiments, may be needed to heat the fractional volumes 18 to promote or accelerate reaction. The heater 78 may include a thermoresistive heater or other similar device. The heater 78 may be controlled through a controller (not shown) or through computer 80.
[0037] The computer 80 in FIG. 6 contains at least one processor 82 therein and runs imaging software. Image frames obtained from the imager 74 can be transferred or otherwise accessed by the computer 80 for image processing. The computer 80 may include a display 84 that is used to display, for example, the 2D array of fractional volumes 18. The display 84 may illustrate the positive fractional volumes 18 that are detected in the device 20, 40. The display 84 may also display a concentration or concentration range that is based in part on the number of positive fractional volumes 18 that are observed in the device 20, 40. Image software such as ImageJ software that is executed by the processor 82 using computer 80 may be used to detect and quantify fluorescently labeled fractional volumes 18. The software may perform background subtractions and contrast enhancement. Filtering can be applied to filter out unwanted spatial frequencies in intensity. This can be used, together with a thresholding or local maxima detection scheme to quantify "positive" results. Namely, a light intensity over a pre-determined threshold value may be characterized as positive. Or over a set of pre-determined values to indicate multiple binding reactions per confined volume in another embodiment. FIGS. 7A and 7B illustrates two images (at different magnifications) of the microwells 46 of the device 40 of FIGS. 4A and 4B. Fluorescent dye (fluorescein) is contained in the microwells 46 which are then imaged with an imaging device 70.
[0038] With the optimal concentration of detector molecules 12, 14, Poisson statistics allow for the calculation of the concentration of the target 10 and number of background fractionated volumes 18 that are likely to fluoresce because Rl and R2 are present in a confined volume by chance. Note that this fluorescent level may be lower than when Rl and R2 are joined by the target 10 such that they are in close proximity to react more rapidly. Tables 1 and 2 below illustrate such calculations, with potential concentrations of interest highlighted (Reaction Component Probability is a proxy for the concentration of the reactants). With very low reaction component concentrations, noise can be minimized (false positive signals generated by fractionated volumes containing reaction component Rl and reaction component Rl without any target present) to allow for extremely low limits of detection. However, with such low concentrations, the calculation of the concentration of the target 10 will have a limited range of possible values. With higher reaction component concentrations, the noise level will be higher, but calculation of the target 10 Poisson statistics will be more accurate for higher concentration range measurements where Rl and Rl are no longer limiting reagents for detecting target 10. This device 20, 40 can be adapted to use whichever concentration level is necessary depending on assay requirements, or potentially, use multiple concentrations in a parallel assay. Table 1
Oil/Water Droplet Fractionation Probability Statistics
Reaction Droplet
Component Max Diameter Droplet Volume Cone High
Probability No. of Droplets Noise Signal (μιη) (L) Cone Low (M) (M)
0.001 1000000 1 1000 10 5.23599E-13 1.15012E-16 1.15012E-13
0.01 1000000 100 10000 10 5.23599E-13 1.15012E-14 1.15012E-12
0.001 1000000 1 1000 5 6.54498E-14 9.20094E-16 9.20094E-13
0.01 1000000 100 10000 5 6.54498E-14 9.20094E-14 9.20094E-12
0.001 10000000 10 10000 10 5.23599E-13 1.15012E-16 1.15012E-13
0.01 10000000 1000 100000 10 5.23599E-13 1.15012E-14 1.15012E-12
0.001 10000000 10 10000 5 6.54498E-14 9.20094E-16 9.20094E-13
0.01 10000000 1000 100000 5 6.54498E-14 9.20094E-14 9.20094E-12
0.001 100000 0.1 100 10 5.23599E-13 1.15012E-16 1.15012E-13
0.01 100000 10 1000 10 5.23599E-13 1.15012E-14 1.15012E-12
0.001 100000 0.1 100 5 6.54498E-14 9.20094E-16 9.20094E-13
0.01 100000 10 1000 5 6.54498E-14 9.20094E-14 9.20094E-12
0.001 1000000 1 1000 20 4.18879E-12 1.43765E-17 1.43765E-14
0.01 1000000 100 10000 20 4.18879E-12 1.43765E-15 1.43765E-13
0.005 1000000 25 5000 20 4.18879E-12 3.59412E-16 7.18823E-14
0.05 1000000 2500 50000 20 4.18879E-12 3.59412E-14 7.18823E-13
0.005 1000000 25 5000 5 6.54498E-14 2.30023E-14 4.60047E-12
0.05 1000000 2500 50000 5 6.54498E-14 2.30023E-12 4.60047E-1 1
0.005 1000000 25 5000 8 2.68083E-13 5.61581E-15 1.12316E-12
0.05 1000000 2500 50000 8 2.68083E-13 5.61581E-13 1.12316E-1 1
0.001 100000 0.1 100 20 4.18879E-12 1.43765E-17 1.43765E-14
0.01 100000 10 1000 20 4.18879E-12 1.43765E-15 1.43765E-13
0.001 100000 0.1 100 15 1.76715E-12 3.40775E-17 3.40775E-14
0.01 100000 10 1000 15 1.76715E-12 3.40775E-15 3.40775E-13
0.005 100000 2.5 500 20 4.18879E-12 3.59412E-16 7.18823E-14
0.05 100000 250 5000 20 4.18879E-12 3.59412E-14 7.18823E-13
0.005 100000 2.5 500 15 1.76715E-12 8.51939E-16 1.70388E-13
0.05 100000 250 5000 15 1.76715E-12 8.51939E-14 1.70388E-12
0.005 100000 2.5 500 30 1.41372E-11 1.06492E-16 2.12985E-14
0.05 100000 250 5000 30 1.41372E-1 1 1.06492E-14 2.12985E-13
0.01 100000 10 1000 30 1.41372E-11 4.25969E-16 4.25969E-14 Table 2
Two-Layer Compression Compartmentalization Probability Statistics
Figure imgf000014_0001
[0039] The concentration or a range of concentrations of the target 10 can then be calculated based at least in part on the number of fractionated volumes 18 emitting a positive emission signal from the image. The number concentration of an initial solution can be estimated by counting the number of fractionated volumes 18 with positive emission signals divided by the sample volume introduced. Over a concentration range described in Tables 1 and 2, concentration is linearly correlated with number of volumes with positive emission signals and calibration with known concentrations can be used to determine the linear coefficient of correlation. The molar concentration can be calculated from this number concentration by dividing by Avogadro's number (6.022 x 1023) and converting volume to units of liters. At higher concentrations, a non-continuous gradation in positive emission signal in fractionated volumes can also be used to estimate concentration as described in Rissin et al, simultaneous detection of single molecules and singulated ensembles of molecules enables immunoassays with broad dynamic range, Anal Chem. 2011 Mar 15;83(6):2279-85, which is incorporated by reference as if set forth fully herein.
[0040] Experimental
[0041] As noted above, in one embodiment of the invention, first reaction component Rl is an enzyme, such as DNA polymerase or several DNA polymerases while the second reaction component R2 is a DNA sequence (single strand or multiple strands). In this experiment, shortened sequences of λ DNA were tested for their ability to amplify and be detected within microwells of the device of the type illustrated in FIGS. 4A and 4B. The experiment utilized loop-mediated isothermal amplification (LAMP) which is an amplification method that amplifies DNA under isothermal conditions using a set of four specialty designed primers and DNA polymerase. Details regarding the LAMP process may be found in Nagamine et al, Accelerated reaction by loop-mediated isothermal amplification using loop primers, Molecular and Cellular Probes, 16, 223-229 (2002), which is
incorporated by reference as if set forth fully herein. The primers used are set forth below.
Table 3
Figure imgf000015_0001
Two shortened sequences of λ DNA were investigated for amplification within the microwells of the device illustrated in FIGS. XX. The shortened sequences included a 600 bp shortened sequence of λ DNA (SEQ ID NO:7) and a lk shortened sequence of λ DNA (SEQ ID NO:8). The LAMP reaction was run with 25 μϊ^ of a 2x reaction mix containing 2M betaine, 40mM Tris-HCL (pH 8.8), 20 mM KCL, 20 mM (NH4)2S04, 12 mM MgS04, 0.2% Triton-X 100, and 3.2 mM dNTPs in combination with DNA, primer mix, SYBR green, DNA polymerase, and water. 5 μΐ^ of DNA (5.74 x 1010 copies/μΕ) was used with 2 μΐ^ of the primer mix. The primer mix included 16 μΜ FIP, 16 μΜ BIP, 2 μΜ F3, 2 μΜ B3, 4 μΜ Loop F, and 4 μΜ Loop B. 2 μΐ, of SYBR® (lOOOx diluted) was used for the fluorescent dye. The solution included 2 μΐ^ of DNA polymerase (BST polymerase, large fragment (8,000 units/mL), and 14 μΐ^ ultrapure water (DNAse/RNAse free water).
[0042] FIG. 8 illustrate DNA electrophoresis gel results illustrating that the LAMP amplification reaction for the entire λ DNA as well as the shortened 600bp and lOOObp λ DNA. All LAMP materials were mixed together on ice and incubated at 65°C for one hour. FIG. 9 illustrates fluorescent images obtained of the device of FIGS. 4A and 4B after the addition of lOOx diluted DNA. In this experiment, all of the LAMP reaction components were mixed together on ice and the device was filled and then compressed. The device was incubated at 65 °C for one hour. The device was then imaged with fluorescein isothiocyanate (FITC) filter set to detect SYBR green fluorescence of double stranded DNA. The device has microwells with diameters of 20 μιη and height of 60 μιη. Both the zero (0) DNA and initial time zero (0) conditions illustrate a low signal to noise ratio (because of the expected low signal). FIG. 9 also illustrates the same microwells after amplification (time = 60 minutes). Note that in the 600 bp and the lk bp experiments, the contrast adjusted microwells show a higher signal to noise ratio (higher signal compared to background noise).
[0043] While embodiments of the present invention have been shown and described, various modifications may be made without departing from the scope of the present invention. The invention, therefore, should not be limited, except to the following claims, and their equivalents.

Claims

What is claimed is:
1. A method of quantifying the concentration of a target within a sample comprising:
generating a plurality of fractionated volumes, wherein at least some of the fractionated volumes contain the target bound to a first detector molecule connected to a first reaction component (Rl) via a linker molecule, the target also bound to a second detector molecule connected to a second reaction component (R2) via a linker molecule;
imaging the plurality of fractionated volumes;
counting the number of fractionated volumes emitting a positive emission signal from the image; and
calculating the concentration or range of concentrations of the target based at least in part on the number of fractionated volumes emitting a positive emission signal from the image.
2. The method of claim 1, wherein the fractionated volumes comprise droplets.
3. The method of claim 1, wherein the fractionated volumes are contained within micro wells.
4. The method of claim 1, wherein a plurality of first reaction components (Rl) are connected to the first detector molecule via a linker molecule.
5. The method of claim 1, wherein a plurality of second reaction components (R2) are connected to the second detector molecule via a linker molecule.
6. The method of claim 1, wherein the first reaction component (Rl) comprises DNA polymerase.
7. The method of claim 6, wherein the second reaction component (R2) comprises a single strand of DNA or multiple strands of DNA.
8. The method of claim 7, wherein the fractionated volumes further comprise a fluorescent marker specific to amplified DNA.
9. The method of claim 1, wherein the calculated concentration is based on a Poisson statistical analysis.
10. The method of claim 1, further comprising initiating a reaction between the first reaction component (Rl) and the second reaction component (R2).
11. The method of claim 1 , wherein initiating the reaction is accomplished by altering the temperature of the fractionated volumes.
12. The method of claim 1, wherein initiating the reaction is accomplished by illuminating the fractionated volumes with light.
13. The method of claim 10, wherein the plurality of fractionated volumes is imaged after a period of time has elapsed.
14. A method of detecting a target within a sample comprising:
generating a plurality of fractionated volumes, wherein at least some of the fractionated volumes contain the target bound to a first detector molecule connected to a first reaction component (Rl), the target also bound to a second detector molecule connected to a second reaction component (R2);
initiating a reaction between the first reaction component (Rl) and the second reaction component (R2);
imaging the plurality of fractionated volumes; and
identifying the fractionated volumes emitting a positive emission signal from the image.
15. The method of claim 14, wherein the first detector molecule is connected to the first reaction component (Rl) via a linker and the second detector molecule is connected to the second reaction component (R2) via a linker.
16. The method of claim 14, wherein the fractionated volumes comprise droplets.
17. The method of claim 14, wherein the fractionated volumes are contained within microwells.
18. The method of claim 14, wherein the first reaction component (Rl) comprises DNA polymerase.
19. The method of claim 18, wherein the second reaction component (R2) comprises a single strand of DNA or multiple strands of DNA.
20. The method of claim 14, wherein the fractionated volumes comprise a fluorescent marker that increases in intensity upon reaction.
21. The method of claim 14, wherein the reaction is initiated by altering the temperature of the fractionated volumes.
22. The method of claim 14, wherein the reaction is initiated by illuminating the fractionated volumes with light.
23. A microfluidic device comprising:
An optically transparent substrate; and
a flexible layer containing a plurality of wells therein, wherein an opening to the plurality of wells faces the substrate and wherein the at least one of the flexible layer or the optically transparent substrate is moveable to selectively seal the plurality of wells from each other.
24. The microfluidic device of claim 23, further comprising an imaging device configured to image the plurality of wells through the optically transparent substrate.
25. A method of using the device of claim 23, comprising
flowing a mixture containing a sample with a target into the wells via a gap formed between the optically transparent substrate and the flexible layer, the mixture containing a first detector molecule connected to a first reaction component (Rl) via a linker molecule and a second detector molecule connected to a second reaction component (R2) via a linker molecule; sealing the plurality of wells from each other by contacting the flexible layer with the optically transparent substrate;
imaging the plurality of wells; and
identifying the wells within the plurality emitting a positive emission signal from the image.
26. The method of claim 25, further comprising counting the number of wells emitting a positive emission signal from the image; and
calculating the concentration of the target based at least in part on the number of wells emitting a positive emission signal from the image.
PCT/US2014/061174 2013-10-18 2014-10-17 Method and device for detecting molecules or particles using fractionalized volumes WO2015058103A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/029,231 US20160257990A1 (en) 2013-10-18 2014-10-17 Method and device for detecting molecules or particles using fractionalized volumes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361892932P 2013-10-18 2013-10-18
US61/892,932 2013-10-18

Publications (1)

Publication Number Publication Date
WO2015058103A1 true WO2015058103A1 (en) 2015-04-23

Family

ID=52828749

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/061174 WO2015058103A1 (en) 2013-10-18 2014-10-17 Method and device for detecting molecules or particles using fractionalized volumes

Country Status (1)

Country Link
WO (1) WO2015058103A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110312923A (en) * 2017-03-14 2019-10-08 凸版印刷株式会社 Analyzing device, parsing kit and resolution system
DE102019112254A1 (en) * 2019-05-10 2020-11-12 Leonhard Kurz Stiftung & Co. Kg Microfluidic arrangement, method for its production and measuring system comprising the microfluidic arrangement and use

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002061391A2 (en) * 2001-01-31 2002-08-08 The University Of Tennessee Research Corporation Methods for detecting interaction of molecules with surface-bound reagents
US7045286B2 (en) * 2000-07-25 2006-05-16 The Trustees Of The University Of Pennsylvania Methods of detecting molecules expressing selected epitopes via fluorescent dyes
EP2090889A1 (en) * 2008-02-15 2009-08-19 Veridex, LLC Method and apparatus for imaging target components in a biological sample using permanent magnets
US20100166608A1 (en) * 2003-05-20 2010-07-01 Fluidigm Corporation Method and system for microfluidic device and imaging thereof
US20110281775A1 (en) * 2007-07-20 2011-11-17 Eppendorf Ag Detection and/or quantification method of target molecules on a solid support

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045286B2 (en) * 2000-07-25 2006-05-16 The Trustees Of The University Of Pennsylvania Methods of detecting molecules expressing selected epitopes via fluorescent dyes
WO2002061391A2 (en) * 2001-01-31 2002-08-08 The University Of Tennessee Research Corporation Methods for detecting interaction of molecules with surface-bound reagents
US20100166608A1 (en) * 2003-05-20 2010-07-01 Fluidigm Corporation Method and system for microfluidic device and imaging thereof
US20110281775A1 (en) * 2007-07-20 2011-11-17 Eppendorf Ag Detection and/or quantification method of target molecules on a solid support
EP2090889A1 (en) * 2008-02-15 2009-08-19 Veridex, LLC Method and apparatus for imaging target components in a biological sample using permanent magnets

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110312923A (en) * 2017-03-14 2019-10-08 凸版印刷株式会社 Analyzing device, parsing kit and resolution system
EP3598104A4 (en) * 2017-03-14 2020-03-25 Toppan Printing Co., Ltd. ANALYSIS DEVICE, ANALYSIS KIT AND ANALYSIS SYSTEM
DE102019112254A1 (en) * 2019-05-10 2020-11-12 Leonhard Kurz Stiftung & Co. Kg Microfluidic arrangement, method for its production and measuring system comprising the microfluidic arrangement and use

Similar Documents

Publication Publication Date Title
Mielczarek et al. Microfluidic blood plasma separation for medical diagnostics: is it worth it?
Herr et al. Integrated microfluidic platform for oral diagnostics
CN110760571B (en) Digital quantitative multi-target co-detection and biological detection
Maguire et al. A review of centrifugal microfluidics in environmental monitoring
Pourhassan-Moghaddam et al. Protein detection through different platforms of immuno-loop-mediated isothermal amplification
JP6130306B2 (en) Rapid quantification of biomolecules and methods in selectively functionalized nanofluidic biosensors
Liu et al. Single-molecule analysis enables free solution hydrodynamic separation using yoctomole levels of DNA
Ragab et al. Recent advances and applications of microfluidic capillary electrophoresis: a comprehensive review (2017–mid 2019)
Luka et al. Comprehensive review of conventional and state-of-the-art detection methods of Cryptosporidium
EP3598133B1 (en) System and method for identifying and quantifying species with nanopores, using complexes of nanoparticles with carrier particles
US9005987B2 (en) Methods for quantitative target detection and related devices and systems
Klebes et al. Emerging multianalyte biosensors for the simultaneous detection of protein and nucleic acid biomarkers
US20130244227A1 (en) Method for amplification-free nucleic acid detection on optofluidic chips
US10060919B2 (en) Longitudinal assay
US20160257990A1 (en) Method and device for detecting molecules or particles using fractionalized volumes
Sharafeldin et al. Alternating magnetic field-promoted nanoparticle mixing: the on-chip immunocapture of serum neuronal exosomes for Parkinson’s disease diagnostics
Zhu et al. Microfluidics-based technologies for the analysis of extracellular vesicles at the single-cell level and single-vesicle level
Shu et al. Portable point-of-care diagnostic devices: an updated review
Van Nguyen et al. Development of a high-throughput centrifugal microsystem for enzyme-linked immunosorbent assay to detect SARS-CoV-2
Zeid et al. Recent advances in microchip electrophoresis for analysis of pathogenic bacteria and viruses
Han et al. On-chip microfluidic dual detection of amino acid metabolism disorders using cell-free protein synthesis
Schulze et al. Multiplexed optical pathogen detection with lab‐on‐a‐chip devices
Oita et al. Microfluidics in macro-biomolecules analysis: macro inside in a nano world
WO2015058103A1 (en) Method and device for detecting molecules or particles using fractionalized volumes
US10436707B2 (en) Detection of analytes using nanoparticles as light scattering enhancers

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14853499

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 15029231

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14853499

Country of ref document: EP

Kind code of ref document: A1

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载